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Abstract Two systemic antiviral resistance-inducing proteins, 
CIP-29 and CIP-34, isolated from Clerodendrum inerme Gaertn. 
leaves, were tested for ribosome-inactivating properties. It was 
found that CIP-29 has the characteristics of a polynucleotide: 
adenosine glycosidase (ribosome-inactivating protein), in that it 
inhibits protein synthesis both in cell-free systems and, at higher 
concentrations, in cells, and releases adenine from ribosomes, 
RNA, poly(A) and DNA. As compared with other known RIPs, 
CIP-29 deadenylates DNA at a high rate, and induces systemic 
antiviral resistance in susceptible plants. 
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I. Introduction 
It is well known that extracts from many plants possess 
antiviral activity, some of them exerting their activity locally, 
i.e. when applied at the site of infection, whilst others induce a 
systemic resistance to viruses (for a recent review see [1]). In 
some cases the antiviral activity, but not the systemic resist- 
ance induction, was due to proteins which were provisionally 
named ribosome-inactivating proteins (RIPs, review in [2]). 
Some proteins with antiviral activity were indeed found to 
be RIPs [3] and, conversely, the antiviral activity in plant 
extracts led to the identification of some new RIPs [4]. Re- 
cently two basic glycoproteins, called CIP-29 and CIP-34, 
which induced a very high degree of systemic resistance 
against obacco mosaic virus in Nicotiana tabacum cv. Samsun 
NN, were purified from Clerodendrum inerme (Verbenaceae) 
[5]. CIP-29 was found to share several characteristics with 
RIPs, viz. (i) it is a monomer  with a molecular mass of 29 
kDa, (ii) it has a basic isoelectric point, and (iii) it is fairly 
resistant to temperature and proteolytic digestion. However, it 
did not cross-react with sera against other RIPs, namely dian- 
thin, momord in  and saporin [5], as expected, since RIPs from 
plants belonging to different families usually do not cross- 
react [6]. 
These apparent similarities prompted us to investigate the 
two proteins in greater detail. One of them, CIP-29, showed 
the characteristics of a RIP  with polynucleotide:adenosine 
glycosidase activity, and its enzymatic activity was studied 
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Abbreviations." RIP, ribosome-inactivating protein 
on several polynucleotides which had previously been found 
to be substrates of RIPs (see Section 4 below). 
2. Materials and methods 
2.1. Chemicals 
The antiviral proteins CIP-29 and CIP-34 were purified from leaves 
of C. inerme as described earlier [5]. [t4C]L-Leucine was from Amer- 
sham International, Buckinghamshire, UK. Adenine and tRNA were 
from Sigma Chemical Co., St. Louis, MO, USA. Poly(A) and rRNA 
from Escherichia coli (16S+23S, m.w. 1.75 x 106) were from Boehrin- 
ger GmbH, Mannheim, Germany. DNA from herring sperm (Sigma) 
was mechanically sheared and made RNA-free by treatment with 
DNase-free RNase A (Boehringer) for 2.5 h at 37°C. DNA was 
then repeatedly precipitated in ethanol to remove the enzyme. Stand- 
ard adenine was from Sigma. All other chemicals were as in previous 
work [7]. 
2.2. Cell cultures 
The cell lines used, namely mouse 3T3 (fibroblasts), and human 
HeLa (carcinoma), NB 100 (neuroblastoma) and BeWo (chorioncar- 
cinoma) were maintained as monolayer cultures in RPMI 1640 me- 
dium supplemented with antibiotics and 10% fetal calf serum, in a 
humidified atmosphere containing 5°/,, CO2, at 37°C. Subcultures 
were obtained by trypsin treatment of confluent cultures. The JM 
cell line (monocyte-derived) was grown in suspension and treated as 
described [8]. 
2.3. Determination of enzyme activities 
The effect of CIP-29 and CIP-34 on protein synthesis in a cell-free 
system (a rabbit reticulocyte lysate) was studied essentially as de- 
scribed [7], with the details given in the legend to Fig. 1. Protein 
synthesis by cells was determined as in [9]. The ICs0 (concentration 
giving 50% inhibition) was calculated by linear regression analysis. 
Unless otherwise stated, polynucleotide:adenosine glycosidase ac- 
tivity was determined by measuring adenine released from various 
substrates by HPLC [10] essentially following the procedure of [11] 
as described by [12]. Reactions were run for 40 rain at 30°C in a final 
volume of 50 I.tl containing 50 mM Na-acetate, pH 4.0, 100 mM KCI 
and RIP and substrate as indicated in the legends to the appropriate 
figures. Controls were run without RIP, and a standard curve of 
adenine was run with each experiment. 
3. Results 
The proteins purified from C. merme inhibited protein 
synthesis by a rabbit reticulocyte lysate, CIP-29 with an 
ICs0 of 5 .48x10 -1° M (16 ng/ml) and CIP-34 with an ICs0 
of 8.74x 10 s M (3 lag/ml) (Fig. 1). The low specific activity 
of CIP-34 led us to analyze this protein by chromatography 
on a Blue-Sepharose column, to which RIPs bind [2]. Most of 
the protein, containing approximately 6% of the inhibitory 
activity, was not bound to the column. The bound protein 
was eluted with a NaC1 gradient giving several small peaks, 
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Fig. 1. Effect of CIP-29 ((3) and CIP-34 (e) on cell-free protein 
synthesis. The effect of the proteins was assayed on globin mRNA- 
directed protein synthesis by a rabbit reticulocyte lysate. The reac- 
tion mixture contained, in a final volume of 62.5 lal: 10 mM Tris- 
HCI buffer, pH 7.4, 100 mM ammonium acetate, 2 mM Mg-acetate, 
1 mM ATP, 0.2 mM GTP, 15 mM phosphocreatine, 3 lag of crea- 
tine kinase, 0.05 mM amino acids (minus leucine), 89 nCi of 
L-[14C]leucine, and 25 lal of rabbit reticulocyte lysate. Incubation 
was for 5 min at 28°C. Control values were 6781 dpm. 
and the activity was distributed along the gradient, not coin- 
ciding with the protein peaks (results not shown). Further 
experiments were performed with CIP-29, on the assumption 
that only this could be a pure RIP (see Section 4 below). Like 
other type 1 RIPs, CIP-29 inhibited protein synthesis by var- 
ious cell lines, although at concentrations much higher than 
those effective in the cell-free system (Table 1). 
That CIP-29 is a RIP was confirmed by the release of ade- 
nine from rat liver ribosomes, up to 1 mol of adenine per 
ribosome (Fig. 2). Since at least some RIPs release adenine 
from purified rRNA and other polynucleotide substrates (see 
Section 1 above), the effect of CIP-29 was tested on different 
types of RNA and on DNA.  It was observed that the CIP-29 
released adenine from rRNA,  tRNA,  poly(A), as well as from 
DNA,  the highest activity being observed with the latter sub- 
strate (Fig. 3). 
4. Discussion 
A characteristic of RIPs is their inhibitory effect on protein 
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Fig. 2. Release of adenine from purified rat liver ribosomes by CIP- 
29. Reaction was run for 40 min at 30°C in a final volume of 50 lal 
containing 30 pmol of ribosomes, 20 mM Tris-HCl, pH 6.8, 100 
mM NH4CI, 7 mM Mg-acetate, 1 mM DTT and RIPs at the indi- 
cated concentrations. 
synthesis. RIPs were found to be peculiar N-glycosidases, and 
to remove a single adenine from a precise position in rRNA 
(A 4324 in the case of rat liver ribosomes) (review in [13]). More 
recently, however, it was reported that some, but not all, RIPs 
remove more than one adenine residue per ribosome [14], and 
that saporins [15,16] and other RIPs ([12]; unpublished results 
by Barbieri et al.) remove adenine from RNA other than 
rRNA and also from DNA. Consistently, ricin removes 2'- 
deoxyadenine from a synthetic dodecanucleotide with a GdA- 
GA loop, actually at a faster rate than it removes adenine 
from a similar dodecanucleotide with a GAGA loop [17]. 
On the basis of these properties the name of polynucleotide: 
adenosine glycosidase was proposed for RIPs. Some RIPs, 
however, have been reported to cleave supercoiled s DNA 
in vitro into linear forms, although they do not have any 
effect on linear DNA itself [18] 
Of the two antiviral proteins isolated from C. inerme only 
CIP-29 showed a significant inhibitory effect on protein syn- 
thesis, both by a cell-free system and by cells, which was com- 
parable to that of other known RIPs [2]. As observed with 
other RIPs [2], the effect on cells varied, BeWo and NB100 
being the most sensitive, and HeLa and 3T3 the most resistant 
lines. That the inhibition on cells occurs only at relatively high 
Table 1 
Effect of CIP-29 on protein synthesis by cell lines 
Cell line Protein synthesis by controls (dpm) IC50 (nM) Correlation coefficient 
HeLa 17 776 + 1 592 > 3 330 n.d. 
NB 100 7345+ 1471 325+ 183 0.96+_0.03 
JM 6 400 + 3 818 678 + 196 0.99 + 0.01 
3T3 11 886 + 5 593 > 3 330 n.d. 
BeWo 53 536 + 2 746 316 + 81 0.99 + 0 
Cells (105/well, in triplicate) were incubated for 18 h in 0.5 ml of RPMI-1640 containing 10% fetal calf serum and various concentrations of CIP-29 
(1.5-3330 nM). The medium was then replaced with serum- and leucine-free RPMI-1640 containing 125 nCi of L-[4,5-3H]leucine and after 2 h the 
cells were collected and the radioactivity incorporated into protein was determined as described in [9]. Results are mean + S.E.M. of two experi- 
ments. 
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Fig. 3. Polynucleotide:adenosine glycosidase activity of the ribo- 
some-inactivating protein CIP-29 assayed with various substrates. 
The substrates were herring sperm DNA (e), poly(A) (©), rRNA 
(• ) ,  tRNA ([]). Reactions were run for 40 min at 30°C in a final 
volume of 50 gl containing 20 gg of substrate, 50 mM Na-acetate, 
pH 4.0, 100 mM KCI and RIPs at the indicated concentrations. 
concentrations uggests that the RIP internalization is not 
mediated by a specific receptor. The other protein, CIP-34, 
was shown to have an inhibitory effect at extremely high con- 
centrations. As suspected [5], this preparation appeared to be 
a mixture of proteins, most of them inactive, and containing 
small amounts of inhibitory activities, possibly due to iso- 
forms of the same RIP, as often occurs in plants (see for 
instance [9]). 
In addition to inhibiting protein synthesis, CIP-29 has the 
enzymatic properties of RIPs in that it releases adenine from 
rat liver ribosomes. Like other RIPs, it is active not only on 
ribosomes, but also on various polynucleotides, thus being a 
polynucleotide:adenosine glycosidase. These effects are cata- 
lytic, as shown by molar ratio less than 1 between RIP present 
in the reaction mixture and adenine released. From the char- 
acteristics of their enzymatic activity, RIPs appear to be a 
non-homogeneous class of enzymes, in that (i) some release 
one, and some more than one adenine residues per ribosome 
[14], (ii) some are more active on poly(A) than on RNA 
[15,16] and (iii) have variable activity on RNA and on 
DNA (unpublished results). CIP-29 releases only one adenine 
residue from rat liver ribosomes, is not particularly active on 
poly(A), but is very active on DNA,  more than any RIP 
assayed so far under the same experimental conditions. This 
indicates (i) that the activity of CIP-29, and presumably of 
other RIPs, on one substrate is independent of the activity on 
other substrates and (ii) that DNA appears to be the best 
polynucleotide substrate for CIP-29. I f  the effect on DNA 
occurs in vivo, it may contribute to the antiviral activity of 
CIP-29 by damaging viral or virally induced DNA.  
The notion that RIPs may have a defensive role against 
viruses is supported by the resistance acquired by plants trans- 
fected with RIP genes [19-21] and, indirectly, by the expres- 
sion of a RIP in tissues of sugar beet plants consequent to 
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viral infection or to treatment with mediators of virally in- 
duced plant acquired resistance [22]. It should be pointed out 
that the exogenous application of CIP-29 rendered a suscep- 
tible plant systemically resistant o subsequent virus inocula- 
tion [5], as do RIPs which are expressed in the plant. It is 
possible that some other substances inducing systemic resist- 
ance to viruses (review in [1]) may also turn out to be RIPs. 
How a locally applied RIP can induce resistance at a distance 
remains unknown. 
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